Document is current
Any future updates will be listed below
-
Authors
Fujita, Hiroaki
Wakiya, Taiichi
Tatara, Yota
Ishido, Keinosuke
Sakamoto, Yoshiyuki
Kimura, Norihisa
Morohashi, Hajime
Miura, Takuya
Muroya, Takahiro
Akasaka, Harue
Yokoyama, Hiroshi
Kanda, Taishu
Kubota, Shunsuke
Ichisawa, Aika
Ogasawara, Kenta
Kuwata, Daisuke
Takahashi, Yoshiya
Nakamura, Akie
Yamazaki, Keisuke
Yamada, Takahiro
Matsuyama, Ryo
Kanou, Masanobu
Yamana, Kei
Itoh, Ken
Hakamada, Kenichi
-
Funding
Funding for this research was provided by:
NOMON Co. Ltd, Japan
- License Information
-
More Information
Article History
Received: 22 January 2024
Accepted: 26 June 2024
First Online: 17 July 2024
Competing interests
: R. Matsuyama is an employee of Teijin Pharma Limited and Teijin Limited. M. Kanou, and K. Yamana are employees of Teijin Limited and are also the board of directors of NOMON Co., Ltd., which is a subsidiary of Teijin Limited. R. Matsuyama has applied for a patent to protect the method of NAD + measurement presented in the manuscript. There are no conflicts of interest for the other authors.
